Compare Hut 8 Corp (HUT) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hut 8 Corp vs BIO-TECHNE Corp — how do they compare? Hut 8 Corp trades at $81.72 (market cap $11.01B), while BIO-TECHNE Corp trades at $72.46 (market cap $11.37B). The key difference: Hut 8 Corp and BIO-TECHNE Corp are close in size by market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Hut 8 Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hut 8 Corp for 11 Days and BIO-TECHNE Corp for 63 Days on average.
| HUT | TECH | |
|---|---|---|
Market Cap | $11.01B | $11.37B |
Volume | 9,892,615 | 3,153,511 |
Sector | Financials | Health |
52-Week High | $133.02 | $72.61 |
52-Week Low | $33.76 | $43.31 |
Typical Hold Time | 11 Days | 63 Days |
Enterprise Value | $18.45B | $11.40B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HUT trades at $89.30, down 3.17% today, with a bearish technical signal and negative earnings momentum. The company reported significant losses with a net income margin of -188.59% despite revenue growth projections. Recent developments include a $1.07 billion credit facility expansion and strong analyst support with 93.75% buy ratings and a $156.79 consensus price target, suggesting substantial upside potential from current levels.
While HUT faces fundamental challenges with persistent losses and negative cash flow, the company's strategic pivot to AI infrastructure and substantial contract pipeline ($26.6B in long-term contracts) offers growth potential. Key risks include execution challenges in transitioning from mining operations and competitive pressures in the rapidly evolving AI infrastructure space. The stock presents a high-risk, high-reward opportunity with significant analyst optimism.
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hut 8 Corp
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
